Research Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- ACRIN Chair Agreement
- ACRIN Chair Agreement
- ACRIN Committee or Subcommittee Chair Agreement
- ACRIN MR Physics Center of Excellence
- ACRIN MR Physics Center of Excellence
- ACRR Fuel Performance Modeling
- ACS Country Project
- ACT with cystic fibrosis
- ACTG A5327 Protocol Chair Support (PCS)
- ACTG EIA-Luminex Biomarker Supplement (Phase I)
- ACTG, Aids Clinical Trials Group
- ACTG, Aids Clinical Trials Group Hepatitis TSG Vice-Chair
- ACTION EQOL STUDY
- Actions of Angiotensin II Along the Nephron to Regulate Blood Pressure
- ACTIV 4a - A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19
- ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
- ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
- Activation & Function Of Human Cam Kinase Iv In T-Cell
- Activation And Function Of Human Cam Kinase Iv In T Cells
- Activation And Function Of Human Cam Kinase Iv In T-Cells
- Activation delay induced heart failure in congenital heart disease
- Activation of critical gene sets for spinal axon repair
- Activation of rapamycin-sensitive TORC1 by endomembrane amino acid transporters
- Activation of Sickle Red Cell Adhesion
- Active and Passive Acoustic Scatterer Discrimination in an Ocean Waveguide
- Active Life Expectancy in Old and Oldest Old Populations
- Active Life Expectancy in Old and Oldest Old Populations
- Active Life Expectancy in Old and Oldest-old Populations
- Active Life Expectancy in Old and Oldest-Old Populations
- Active Life Expectancy in Old and Oldest-Old Populations